Secondary Logo

Institutional members access full text with Ovid®

Innovative Multimodal Training Program for Family Physicians Leads to Positive Outcomes Among Their HIV-Positive Patients

Kang, Helen, PhD; Cui, Zishan, MSc; Chia, Jason (Tzu, Nien), BSc; Khorsandi Zardoshti, Amanda, BSc; Barrios, Rolando, MD; Lima, Viviane, Dias, PhD; Guillemi, Silvia, MD

Journal of Continuing Education in the Health Professions: January 2018 - Volume 38 - Issue 1 - p 60–65
doi: 10.1097/CEH.0000000000000189
Innovations
Buy

Abstract: CME programs can increase physicians' uptake and adherence to clinical guidelines for chronic diseases. We developed an intensive multimodal training program for family physicians to increase their competency in the management and treatment of HIV, through group learning and via close interactions with expert clinicians in HIV. We trained 51 physicians from September 2010 to June 2015 and compared their adherence to clinical guidelines 1 year before and 1 year after the program. We observed significant increases in the physicians' HIV-related clinical competencies, in accordance with clinical guidelines, and an increase in the number of HIV-positive patients seen by these physicians and the number of combination antiretroviral therapies prescribed by these physicians. By combining various pedagogical approaches, as well as creating and encouraging communities of practice, we were able to make a durable impact on physician performance and patient-specific outcomes.

Dr. Kang: Independent Scholar. Ms. Cui: Biostatistician, BC Centre for Excellence in HIV/AIDS. Mr. Chia: Data Analyst, BC Centre for Excellence in HIV/AIDS. Ms. Khorsandi Zardoshti: Clinical Education Program Coordinator, BC Centre for Excellence in HIV/AIDS. Dr. Barrios: Senior Medical Director, Vancouver Community Health Services, Vancouver Coastal Health Authority. Dr. Lima: Research Scientist/Senior Statistician, Epidemiology and Population Health Program, BC Centre for Excellence in HIV/AIDS. Dr. Guillemi: Director of Clinical Education, BC Centre for Excellence in HIV/AIDS.

Correspondence: Helen Kang, PhD; e-mail: Helen@helenkang.ca.

Disclosures: In the past 2 years (November 2015 to November 2017), S.G. has been invited to attend Advisory Board meetings by pharmaceutical companies and has received honoraria for her participation. These companies include Gilead and ViiV Healthcare. The remaining authors declare no conflict of interest.

© 2018 Lippincott Williams & Wilkins, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website